The first prospective trial for von Hippel-Lindau disease: pazopanib

Rachel H Giles, Sven Gläsker

Onderzoeksoutput: Article › peer review

4 Citaten (Scopus)

Toegang tot document

@article{16ce2e1ced6d4bfc9ba5320dde90678e,

title = "The first prospective trial for von Hippel-Lindau disease: pazopanib",

author = "Giles, {Rachel H} and Sven Gl{\"a}sker",

year = "2018",

month = oct,

day = "1",

doi = "10.1016/S1470-2045(18)30533-3",

language = "English",

volume = "19",

pages = "1267--1269",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "10",

}

TY - JOUR

T1 - The first prospective trial for von Hippel-Lindau disease

T2 - pazopanib

AU - Giles, Rachel H

AU - Gläsker, Sven

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85054771308&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30533-3

DO - 10.1016/S1470-2045(18)30533-3

M3 - Article

C2 - 30236512

VL - 19

SP - 1267

EP - 1269

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 10

ER -